Related Experiment Videos
Differences in substrate specificities of monoamine oxidase A from human liver and placenta
A K Tan1, W Weyler, J I Salach
1Department of Biochemistry and Biophysics, University of California, San Francisco 94143.
Abstract:
The substrate specificities of monoamine oxidase (MAO) A isolated from human placenta and of human liver expressed in yeast have been compared in homogeneous preparations with respect to Vmax and Km values for natural and synthetic substrates and Ki values for competitive inhibitors. MAO A from these two sources is known to differ in at least 5 amino acid residues. While the Km and Ki values were found to be nearly identical in the enzymes from these two sources, the Vmax differed significantly on bulky synthetic substrates.
Insights
Human placental and liver monoamine oxidase A (MAO A) enzymes showed similar substrate affinities (Km) and inhibitor binding (Ki). However, Vmax values differed significantly for bulky synthetic substrates, indicating distinct catalytic efficiencies.
Area of Science:
- Biochemistry
- Enzymology
- Pharmacology
Background:
- Monoamine oxidase A (MAO A) is a crucial enzyme in neurotransmitter metabolism.
- MAO A exists in different isoforms, with variations potentially affecting substrate specificity.
- Understanding these variations is key to developing targeted therapeutics.
Purpose of the Study:
- To compare the substrate specificities of human placental MAO A and human liver MAO A expressed in yeast.
- To investigate differences in kinetic parameters (Vmax, Km) and inhibitor constants (Ki).
Main Methods:
- Enzyme kinetics assays were performed on homogeneous preparations of MAO A from human placenta and yeast-expressed human liver.
- Vmax, Km, and Ki values were determined for natural and synthetic substrates and competitive inhibitors.
Main Results:
- Km and Ki values were nearly identical between placental and liver MAO A.
- Significant differences in Vmax were observed when using bulky synthetic substrates.
- These kinetic differences suggest functional variations despite structural similarities.
Conclusions:
- Human placental and liver MAO A exhibit distinct catalytic efficiencies, particularly with bulky synthetic substrates.
- Despite differing amino acid residues, core substrate recognition (Km, Ki) remains largely conserved.
- Kinetic differences highlight the importance of considering enzyme source in MAO A research and drug development.